Armstrong T - Search Results

1

Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Gamrekelashvili J, Kapanadze T, Han M, Wissing J, Ma C, Jaensch L, Manns MP, Armstrong T, Jaffee E, White AO, Citrin DE, Korangy F, Greten TF. Gamrekelashvili J, et al. Among authors: armstrong t. J Clin Invest. 2013 Nov;123(11):4755-68. doi: 10.1172/JCI65698. J Clin Invest. 2013. PMID: 24216478 Free PMC article.

2

Cytokine modified tumor vaccines.

Armstrong TD, Jaffee EM. Armstrong TD, et al. Surg Oncol Clin N Am. 2002 Jul;11(3):681-96. doi: 10.1016/s1055-3207(02)00020-0. Surg Oncol Clin N Am. 2002. PMID: 12487062 Review.

3

Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.

Thomas AM, Santarsiero LM, Lutz ER, Armstrong TD, Chen YC, Huang LQ, Laheru DA, Goggins M, Hruban RH, Jaffee EM. Thomas AM, et al. J Exp Med. 2004 Aug 2;200(3):297-306. doi: 10.1084/jem.20031435. J Exp Med. 2004. PMID: 15289501 Free PMC article.

4

OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.

Murata S, Ladle BH, Kim PS, Lutz ER, Wolpoe ME, Ivie SE, Smith HM, Armstrong TD, Emens LA, Jaffee EM, Reilly RT. Murata S, et al. J Immunol. 2006 Jan 15;176(2):974-83. doi: 10.4049/jimmunol.176.2.974. J Immunol. 2006. PMID: 16393983

5

A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.

Manning EA, Ullman JG, Leatherman JM, Asquith JM, Hansen TR, Armstrong TD, Hicklin DJ, Jaffee EM, Emens LA. Manning EA, et al. Clin Cancer Res. 2007 Jul 1;13(13):3951-9. doi: 10.1158/1078-0432.CCR-07-0374. Clin Cancer Res. 2007. PMID: 17606729

6

Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.

Kim PS, Armstrong TD, Song H, Wolpoe ME, Weiss V, Manning EA, Huang LQ, Murata S, Sgouros G, Emens LA, Reilly RT, Jaffee EM. Kim PS, et al. J Clin Invest. 2008 May;118(5):1700-11. doi: 10.1172/JCI34333. J Clin Invest. 2008. PMID: 18398507 Free PMC article.

7

Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.

Pfannenstiel LW, Lam SS, Emens LA, Jaffee EM, Armstrong TD. Pfannenstiel LW, et al. Cell Immunol. 2010;263(1):79-87. doi: 10.1016/j.cellimm.2010.03.001. Epub 2010 Mar 6. Cell Immunol. 2010. PMID: 20346445 Free PMC article.

8

Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma.

Leao IC, Ganesan P, Armstrong TD, Jaffee EM. Leao IC, et al. Clin Transl Sci. 2008 Dec;1(3):228-39. doi: 10.1111/j.1752-8062.2008.00070.x. Clin Transl Sci. 2008. PMID: 20357913 Free PMC article.

9

CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response.

Le DT, Ladle BH, Lee T, Weiss V, Yao X, Leubner A, Armstrong TD, Jaffee EM. Le DT, et al. Among authors: armstrong td. Int J Cancer. 2011 Aug 1;129(3):636-47. doi: 10.1002/ijc.25693. Epub 2010 Nov 12. Int J Cancer. 2011. PMID: 20857491 Free PMC article.

10

Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Uram JN, Black CM, Flynn E, Huang L, Armstrong TD, Jaffee EM. Uram JN, et al. J Immunol. 2011 Apr 1;186(7):3847-57. doi: 10.4049/jimmunol.1000361. Epub 2011 Feb 23. J Immunol. 2011. PMID: 21346233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

912 results

Search Page

Filters